Last reviewed on RxList: 3/6/2009
Mononine Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 6/15/2016

Mononine (coagulation factor IX human) is a clotting factor used to treat or prevent bleeding in people with hemophilia B. Mononine is not for treating people with hemophilia A factor VII deficiency. Mononine is available in generic form. Common side effects of Mononine include:

  • headache
  • flushing (warmth or tingly feeling under your skin)
  • nausea
  • vomiting
  • dizziness, or
  • injection site reactions (pain, redness, or swelling)

The dose of Mononine to be infused, as well as the frequency of infusions, will vary with each patient and with the clinical situation. Mononine may interact with other drugs. Tell your doctor all medications and supplements you use. Mononine may be harmful to a fetus. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is unknown if this drug passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.

Our Mononine (coagulation factor IX human) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Digestive Disorders: Common Misconceptions See Slideshow
Mononine Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives, itching; wheezing, tightness in your chest, difficult breathing, fast heartbeats, blue lips, feeling like you might pass out; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • swelling in your hands, feet, or ankles;
  • swelling in your waist, weight gain;
  • loss of appetite;
  • fever or chills;
  • continued bleeding after treatment;
  • new or worsened bleeding; or
  • signs of excessive blood clotting--sudden numbness or weakness (especially on one side of the body), slurred speech, problems with vision or balance, chest pain, coughing up blood, or pain, swelling, warmth and redness in one or both legs.

Common side effects may include:

  • nausea;
  • headache;
  • dizziness;
  • altered sense of taste;
  • mild skin rash; or
  • pain, redness, itching, stinging, or other irritation where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Mononine (Coagulation Factor IX (Human))


About how much does an adult human brain weigh? See Answer
Mononine Professional Information


As with the intravenous administration of other plasma-derived products, the following reactions may be observed following administration: headache, fever, chills, flushing, nausea, vomiting, tingling, lethargy, hives, stinging or burning at the infusion site or manifestations of allergic reactions. In a clinical study with Mononine® (coagulation factor ix (human)) in previously untreated hemophilia Bpatients, five patients experienced ALTelevations. Serologic tests for hepatitis A, hepatitis B, hepatitis C, Cytomegalovirus, and Epstein-Barr virus were negative.

The following adverse reactions have been spontaneously reported during post-marketing use of Mononine® (coagulation factor ix (human)) as well as other Factor IX products:anaphylaxis, angioedema, cyanosis, dyspnea, hypotension, thrombosis, inadequate therapeutic response, and inhibitor development.

There is a potential risk of thromboembolic episodes following the administration of Mononine® (see WARNINGS and PRECAUTIONS).

The patient should be monitored closely during the infusion of Mononine® (coagulation factor ix (human)) to observe for the development of any reaction. If any reaction takes place that is thought to be related to the administration of Mononine® (coagulation factor ix (human)) , the rate of infusion should be decreased or the infusion stopped, as dictated by the response of the patient. Should evidence of an acute hypersensitivity reaction be observed, the infusion should be stopped promptly and appropriate countermeasures and supportive therapy should be administered.

Read the entire FDA prescribing information for Mononine (Coagulation Factor IX (Human))

© Mononine Patient Information is supplied by Cerner Multum, Inc. and Mononine Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors